Status:

NOT_YET_RECRUITING

ZIPPER™ Stent-Graft Trial for Aortic Arch Dissection

Lead Sponsor:

Hangzhou Endonom Medtech Co., Ltd.

Conditions:

Dissection of Aortic Arch

Eligibility:

All Genders

18-80 years

Phase:

NA

Brief Summary

This study is the feasible study on a new technique of ZIPPER aortic arch stentgraft system

Detailed Description

The study of ZIPPER aortic arch stentgraft system is a prospective, multicenter, single arm trial, which will enroll a total of 127 patients. The goal of this study is to evaluate the safety and effic...

Eligibility Criteria

Inclusion

  • Age: 18-80 years of age.
  • Diagnosis and Anatomical Suitability:
  • Subacute or chronic aortic arch dissection requiring intervention, where the proximal end of the stent graft requires anchoring in Zone 0, and meets the following vascular anatomical criteria:
  • Ascending aorta (may include graft segments) ≥ 40 mm in length (measured from the sinotubular junction to the proximal edge of the IA along the centerline).
  • Proximal landing zone diameter ≥ 24 mm and ≤ 47 mm. Proximal landing zone length ≥ 20 mm. Diameters of the IA, LCCA, and LSA ≤ 24 mm and ≥ 6 mm, with lengths ≥ 20 mm. Suitable arterial access for endovascular intervention. Informed Consent: Capable of understanding the study purpose, voluntarily agreeing to participate, and providing written informed consent (by the subject or their legal representative). Willing to comply with follow-up requirements per the protocol.
  • Surgical Risk Assessment: Deemed high surgical risk (evaluated by at least two independent vascular or cardiac surgeons) or confirmed to have significant contraindications to open surgery.

Exclusion

  • Prior aortic intervention: History of open or endovascular repair of the descending or abdominal aorta.
  • Concurrent AAA requiring intervention: Coexisting abdominal aortic aneurysm requiring surgical intervention within 30 days.
  • Specific aortic pathologies: infectious aortitis, Takayasu arteritis, Marfan syndrome, or other connective tissue disorders.
  • Active systemic infection: Ongoing systemic infection or high risk of systemic infection.
  • Severe arch vessel disease: Severe stenosis, calcification, thrombosis, or tortuosity of the IA, LCCA, or LSA.
  • Acute ischemia: Bowel necrosis or lower limb ischemic necrosis. Pre-existing paraplegia. Post-cardiac transplant status. Recent cardiovascular events: Myocardial infarction or stroke within the past 3 months.
  • Advanced heart failure: NYHA Class IV or left ventricular ejection fraction (LVEF) \<30%.
  • Active gastrointestinal bleeding: Active peptic ulcer or upper gastrointestinal bleeding within the past 3 months.
  • Hematologic abnormalities: Leukopenia (WBC \< 3×10⁹/L), Anemia (Hb \< 90 g/L), Coagulopathy, Thrombocytopenia (platelets \< 50×10⁹/L).
  • Renal insufficiency: Serum creatinine \> 221 μmol/L (2.5 mg/dL) or end-stage renal disease requiring dialysis (investigator discretion).
  • Severe hepatic dysfunction: ALT/AST \> 5× upper limit of normal (ULN), Serum total bilirubin (STB) \> 2× ULN.
  • High-risk intracranial lesions (any of the following):
  • Unruptured aneurysm ≥7 mm (anterior circulation) or ≥5 mm (posterior circulation)
  • Prior rupture or high-risk morphology (daughter sac, aspect ratio \>1.6)
  • Intracranial arterial stenosis ≥50% with poor collateral flow. Contrast allergy. Pregnancy or lactation. Anesthesia/surgery contraindications: Severe comorbidities precluding tolerance to anesthesia or surgery.
  • Life expectancy \< 12 months. Current participation in other drug or device clinical trials. Other exclusions: Any conditions deemed unsuitable for participation by the investigator.

Key Trial Info

Start Date :

September 30 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

September 30 2032

Estimated Enrollment :

127 Patients enrolled

Trial Details

Trial ID

NCT07170332

Start Date

September 30 2025

End Date

September 30 2032

Last Update

September 15 2025

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.